Variant report

Variant	nsv963491
Chromosome Location	chr3:154795648-154803797
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:186)
CpG islands
(count:1040)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:186 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:154797474-154798778	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr3:154796747-154796753	K562	blood:	n/a	n/a
3	BHLHE40	chr3:154796861-154796873	K562	blood:	n/a	n/a
4	BHLHE40	chr3:154797570-154798230	K562	blood:	n/a	n/a
5	CCNT2	chr3:154797526-154798068	K562	blood:	n/a	n/a
6	CHD1	chr3:154797021-154797201	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD1	chr3:154797947-154798281	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD2	chr3:154797668-154798209	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTBP2	chr3:154797512-154798221	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr3:154797260-154797410	HMF	breast:	n/a	n/a
11	CTCF	chr3:154797260-154797410	AG09319	gingival:	n/a	n/a
12	CTCF	chr3:154797058-154797272	K562	blood:	n/a	n/a
13	CTCF	chr3:154800340-154800490	HEEpiC	esophagus:	n/a	n/a
14	CTCF	chr3:154797240-154797390	AG09309	skin:	n/a	n/a
15	CTCF	chr3:154800100-154800250	MCF-7	breast:	n/a	n/a
16	CTCF	chr3:154797820-154797970	SK-N-SH_RA	brain:	n/a	chr3:154797904-154797917
17	CTCF	chr3:154797240-154797390	SK-N-SH_RA	brain:	n/a	n/a
18	CTCF	chr3:154797340-154797490	WERI-Rb-1	eye:	n/a	n/a
19	CTCF	chr3:154800280-154800430	HRPEpiC	eye:	n/a	n/a
20	CTCF	chr3:154797220-154797370	HMF	breast:	n/a	n/a
21	CTCF	chr3:154797240-154797390	HRPEpiC	eye:	n/a	n/a
22	CTCF	chr3:154797260-154797410	HCFaa	heart:	n/a	n/a
23	CTCF	chr3:154800260-154800410	HPAF	blood vessel:	n/a	n/a
24	CTCF	chr3:154797060-154797210	NHLF	lung:	n/a	n/a
25	CTCF	chr3:154797300-154797450	HUVEC	blood vessel:	n/a	n/a
26	CTCF	chr3:154800240-154800390	HPAF	blood vessel:	n/a	n/a
27	CTCF	chr3:154797260-154797410	AoAF	blood vessel:	n/a	n/a
28	CTCF	chr3:154800280-154800430	HMF	breast:	n/a	n/a
29	CTCF	chr3:154797260-154797410	HMEC	breast:	n/a	n/a
30	CTCF	chr3:154797300-154797450	AG04449	skin:	n/a	n/a
31	CTCF	chr3:154797200-154797350	BJ	skin:	n/a	n/a
32	CTCF	chr3:154797298-154797422	H1-hESC	embryonic stem cell:	n/a	n/a
33	CTCF	chr3:154797280-154797430	HCM	heart:	n/a	n/a
34	CTCF	chr3:154796960-154797110	AG09309	skin:	n/a	n/a
35	CTCF	chr3:154797240-154797390	HBMEC	blood vessel:	n/a	n/a
36	CTCF	chr3:154800220-154800370	NHDF-neo	bronchial:	n/a	n/a
37	CTCF	chr3:154800280-154800430	HMEC	breast:	n/a	n/a
38	CTCF	chr3:154796860-154797130	AG04450	lung:	n/a	n/a
39	CTCF	chr3:154797240-154797390	AG04450	lung:	n/a	n/a
40	CTCF	chr3:154797320-154797470	AG04449	skin:	n/a	n/a
41	CTCF	chr3:154797260-154797410	BJ	skin:	n/a	n/a
42	CTCF	chr3:154800540-154800690	HRPEpiC	eye:	n/a	n/a
43	CTCF	chr3:154797240-154797390	HPAF	blood vessel:	n/a	n/a
44	CTCF	chr3:154797120-154797270	AG04450	lung:	n/a	n/a
45	CTCF	chr3:154797160-154797310	HFF-Myc	foreskin:	n/a	n/a
46	CTCF	chr3:154797280-154797430	NHDF-neo	bronchial:	n/a	n/a
47	CTCF	chr3:154797000-154797150	HPF	lung:	n/a	n/a
48	CTCF	chr3:154797000-154797150	AG04449	skin:	n/a	n/a
49	CTCF	chr3:154797060-154797210	HCM	heart:	n/a	n/a
50	CTCF	chr3:154800400-154800550	AG04450	lung:	n/a	n/a

(count:1040 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:154797508-154797558	BE2_C	brain:	n/a
2	chr3:154796701-154796751	GM19239	blood:	n/a
3	chr3:154797867-154797917	U87	brain:	n/a
4	chr3:154797508-154797558	BE2_C	brain:	n/a
5	chr3:154796701-154796751	GM19239	blood:	n/a
6	chr3:154797867-154797917	U87	brain:	n/a
7	chr3:154797508-154797558	HPAEpiC	pulmonary alveolar:	n/a
8	chr3:154797592-154797642	Jurkat	blood:	n/a
9	chr3:154798079-154798129	GM06990	blood:	n/a
10	chr3:154797947-154797997	U87	brain:	n/a
11	chr3:154797563-154797613	K562	blood:	n/a
12	chr3:154797892-154797942	Caco-2	colon:	n/a
13	chr3:154797958-154798008	RPTEC	kidney:	n/a
14	chr3:154797677-154797727	A549	lung:	n/a
15	chr3:154797349-154797399	HIPEpiC	eye:	n/a
16	chr3:154797677-154797727	IMR90	lung:	fetal
17	chr3:154797592-154797642	PrEC	prostate:	n/a
18	chr3:154797958-154798008	HCT-116	colon:	n/a
19	chr3:154797917-154797967	HepG2	liver:	n/a
20	chr3:154797349-154797399	ovcar-3	ovarian:	n/a
21	chr3:154797677-154797727	HNPCEpiC	eye:	n/a
22	chr3:154797892-154797942	GM19239	blood:	n/a
23	chr3:154797592-154797642	HCF	heart:	n/a
24	chr3:154797677-154797727	SKMC	muscle:	n/a
25	chr3:154797399-154797449	IMR90	lung:	fetal
26	chr3:154797917-154797967	HCF	heart:	n/a
27	chr3:154797349-154797399	NT2-D1	testis:	n/a
28	chr3:154797958-154798008	HCPEpiC	choroid plexus:	n/a
29	chr3:154797958-154798008	BE2_C	brain:	n/a
30	chr3:154797399-154797449	SK-N-SH_RA	brain:	n/a
31	chr3:154797947-154797997	HAEpiC	amniotic membrane:	n/a
32	chr3:154796861-154796911	HMEC	breast:	n/a
33	chr3:154797508-154797558	SAEC	small airway:	n/a
34	chr3:154797589-154797639	MCF-7	breast:	n/a
35	chr3:154797592-154797642	HIPEpiC	eye:	n/a
36	chr3:154797947-154797997	NHDF-neo	bronchial:	n/a
37	chr3:154797892-154797942	HRPEpiC	eye:	n/a
38	chr3:154797677-154797727	HRCEpiC	kidney:	n/a
39	chr3:154797563-154797613	HRCEpiC	kidney:	n/a
40	chr3:154797958-154798008	HepG2	liver:	n/a
41	chr3:154797892-154797942	BJ	skin:	n/a
42	chr3:154798079-154798129	CMK	blood:	n/a
43	chr3:154797779-154797829	BE2_C	brain:	n/a
44	chr3:154797917-154797967	SKMC	muscle:	n/a
45	chr3:154797917-154797967	Hepatocyte	liver:	n/a
46	chr3:154797779-154797829	U87	brain:	n/a
47	chr3:154798079-154798129	AoSMC	blood vessel:	n/a
48	chr3:154797947-154797997	AG04450	lung:	fetal
49	chr3:154797589-154797639	NT2-D1	testis:	n/a
50	chr3:154797589-154797639	ovcar-3	ovarian:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr3:154788960..154792081-chr3:154794108..154796605,3	MCF-7	breast:
2	chr3:154794372..154796771-chr3:154800533..154803148,2	MCF-7	breast:

No data

Variant related genes	Relation type
MME	TF binding region
MME	CpG island
ENSG00000196549	chromatin interactions

Extended variants
information (count: 383 )
Associated
traits (count: 51 )

Variant overlapped rSNPs/rCNVs (count:383 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs113892746	chr3:154795648-154795649	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs575291234	chr3:154795657-154795658	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs546153661	chr3:154795682-154795683	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs150432871	chr3:154795780-154795781	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs185969188	chr3:154795813-154795814	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs112123964	chr3:154795834-154795835	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs376173632	chr3:154795835-154795836	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs34585642	chr3:154795865-154795866	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs200879860	chr3:154795866-154795867	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs35994024	chr3:154795867-154795868	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs61677194	chr3:154795868-154795869	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs533601961	chr3:154795874-154795875	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs540008581	chr3:154795893-154795894	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs562223007	chr3:154795920-154795921	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs539595572	chr3:154795935-154795936	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs550585683	chr3:154795990-154795991	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs552068690	chr3:154796002-154796003	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs371293784	chr3:154796006-154796007	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs35309296	chr3:154796040-154796041	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs533143650	chr3:154796043-154796044	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs551702248	chr3:154796055-154796056	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs374167837	chr3:154796060-154796061	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs563974389	chr3:154796079-154796080	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs138353847	chr3:154796118-154796119	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs534413396	chr3:154796174-154796175	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs3773907	chr3:154796181-154796182	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs55705607	chr3:154796197-154796198	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs535224519	chr3:154796209-154796210	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs191105794	chr3:154796211-154796212	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs146256654	chr3:154796269-154796270	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs115397404	chr3:154796276-154796277	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs539439153	chr3:154796344-154796345	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs1836914	chr3:154796360-154796361	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs548691051	chr3:154796386-154796387	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs573016318	chr3:154796387-154796388	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs3773906	chr3:154796390-154796391	Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs561706942	chr3:154796426-154796427	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs531692651	chr3:154796438-154796439	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs573761901	chr3:154796440-154796441	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs149949372	chr3:154796448-154796449	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs1836913	chr3:154796456-154796457	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs5853711	chr3:154796480-154796481	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs56847112	chr3:154796481-154796482	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs562637520	chr3:154796507-154796508	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs534397076	chr3:154796543-154796544	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs546706816	chr3:154796587-154796588	Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs533157278	chr3:154796603-154796604	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs551319988	chr3:154796623-154796624	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs149539086	chr3:154796633-154796634	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs35900633	chr3:154796645-154796646	Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:51)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Neurodevelopmental disorder	22521361	CNVD
Bladder cancer	21909424	CNVD
Ovarian clear cell carcinoma	21343371	CNVD

Chromatin state (count:527 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:154789000-154796600	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr3:154789200-154796200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr3:154789200-154796400	Weak transcription	HMEC	breast
4	chr3:154789200-154797400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr3:154789400-154796400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr3:154789600-154796200	Weak transcription	Osteobl	bone
7	chr3:154789600-154796400	Weak transcription	HUVEC	blood vessel
8	chr3:154789600-154796600	Weak transcription	HSMMtube	muscle
9	chr3:154794200-154796400	Enhancers	Dnd41	blood
10	chr3:154794600-154796000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr3:154794600-154796000	Enhancers	NHDF-Ad	bronchial
12	chr3:154794800-154796200	Weak transcription	Placenta Amnion	Placenta Amnion
13	chr3:154795000-154795800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
14	chr3:154795000-154796600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr3:154795200-154796600	Weak transcription	K562	blood
16	chr3:154795400-154795800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr3:154795800-154796000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr3:154795800-154796000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
19	chr3:154795800-154796600	Bivalent Enhancer	Fetal Brain Male	brain
20	chr3:154796000-154796200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr3:154796000-154796400	Enhancers	Breast Myoepithelial Primary Cells	Breast
22	chr3:154796000-154796600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr3:154796000-154796800	Flanking Active TSS	NHDF-Ad	bronchial
24	chr3:154796000-154802200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr3:154796200-154796400	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
26	chr3:154796200-154796400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
27	chr3:154796200-154796400	Enhancers	Fetal Kidney	kidney
28	chr3:154796200-154796400	Enhancers	Placenta Amnion	Placenta Amnion
29	chr3:154796200-154796400	Enhancers	Osteobl	bone
30	chr3:154796200-154799600	Active TSS	ES-I3 Cell Line	embryonic stem cell
31	chr3:154796200-154799600	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr3:154796400-154796600	Active TSS	H1 Cell Line	embryonic stem cell
33	chr3:154796400-154796600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
34	chr3:154796400-154796600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
35	chr3:154796400-154796600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr3:154796400-154796600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
37	chr3:154796400-154796600	Active TSS	Primary B cells from cord blood	blood
38	chr3:154796400-154796600	Active TSS	Primary hematopoietic stem cells	blood
39	chr3:154796400-154796600	Enhancers	Primary hematopoietic stem cells short term culture	blood
40	chr3:154796400-154796600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr3:154796400-154796600	Bivalent/Poised TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr3:154796400-154796600	Active TSS	Adipose Nuclei	Adipose
43	chr3:154796400-154796600	Flanking Bivalent TSS/Enh	Fetal Lung	lung
44	chr3:154796400-154796600	Enhancers	HMEC	breast
45	chr3:154796400-154796600	Enhancers	HSMM	muscle
46	chr3:154796400-154796600	Enhancers	HUVEC	blood vessel
47	chr3:154796400-154796800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
48	chr3:154796400-154796800	Active TSS	Brain Anterior Caudate	brain
49	chr3:154796400-154796800	Flanking Active TSS	Fetal Kidney	kidney
50	chr3:154796400-154797000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links